The HLA class I immunopeptidomes of AAV capsid proteins

Frontiers in Immunology

Immunology

Carlos A. Brito-Sierra¹  Megan B. Lannan¹  Robert W. Siegel¹  Laurent P. Malherbe¹ 

[1] Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States;

关键词: aav;    HLA class I;    gene therapy;    CD8+;    proteomics;   

DOI  :  10.3389/fimmu.2023.1212136

 received in 2023-04-25, accepted in 2023-07-26,  发布年份 2023

来源: Frontiers

【 摘 要 】

IntroductionCellular immune responses against AAV vector capsid represent an obstacle for successful gene therapy. Previous studies have used overlapping peptides spanning the entire capsid sequence to identify T cell epitopes recognized by AAV-specific CD8+ T cells. However, the repertoire of peptides naturally displayed by HLA class I molecules for CD8 T cell recognition is unknown.MethodsUsing mRNA transfected monocyte-derived dendritic cells (MDDCs) and MHC-associated peptide proteomics (MAPPs), we identified the HLA class I immunopeptidomes of AAV2, AAV6 and AAV9 capsids. MDDCs were isolated from a panel of healthy donors that have diverse alleles across the US population. mRNA-transfected MDDCs were lysed, the peptide:HLA complexes immunoprecipitated, and peptides eluted and analyzed by mass spectrometry.ResultsWe identified 65 AAV capsid-derived peptides loaded on HLA class I molecules of mRNA transfected monocyte derived dendritic cells. The HLA class I peptides are distributed along the entire capsid and more than 60% are contained within HLA class II clusters. Most of the peptides are organized as single species, however we identified twelve clusters containing at least 2 peptides of different lengths. Only 9% of the identified peptides have been previously identified as T cell epitopes, demonstrating that the immunogenicity potential for the vast majority of the AAV HLA class I immunopeptidome remains uncharacterized. In contrast, 12 immunogenic epitopes identified before were not found to be naturally processed in our study. Remarkably, 11 naturally presented AAV peptides were highly conserved among the three serotypes analyzed suggesting the possibility of cross-reactive AAV-specific CD8 T cells.DiscussionThis work is the first comprehensive study identifying the naturally displayed HLA class I peptides derived from the capsid of AAVs. The results from this study can be used to generate strategies to assess immunogenicity risk and cross-reactivity among serotypes during gene therapies.

【 授权许可】

Unknown   
Copyright © 2023 Brito-Sierra, Lannan, Malherbe and Siegel